These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38104333)

  • 1. Bladder metastasis from inflammatory breast cancer presenting with hematuria and hydronephrosis.
    Foss HE; Bulafka J; Nwaoduah N; Shah MS
    Can J Urol; 2023 Dec; 30(6):11747-11751. PubMed ID: 38104333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
    Nakhlis F
    Ann Surg Oncol; 2022 Oct; 29(10):6106-6113. PubMed ID: 35840847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring Treatment for Patients with Inflammatory Breast Cancer.
    Newman AB; Lynce F
    Curr Treat Options Oncol; 2023 Jun; 24(6):580-593. PubMed ID: 37043118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.
    Fujii T; Mason J; Chen A; Kuhn P; Woodward WA; Tripathy D; Newton PK; Ueno NT
    Oncologist; 2019 Oct; 24(10):1322-1330. PubMed ID: 30952823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematuria in breast cancer: don't forget bladder metastases!
    Caputo A; Addesso M; Fraggetta F; D'Antonio A
    Pathologica; 2022 Apr; 114(2):170-173. PubMed ID: 35481569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary surgical management of inflammatory breast cancer: a narrative review.
    Adesoye T; Irwin S; Sun SX; Lucci A; Teshome M
    Chin Clin Oncol; 2021 Dec; 10(6):57. PubMed ID: 35016511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone Receptor Positive/HER2 Negative Breast Cancer With Isolated Bladder Metastasis: A Rare Case.
    Khan NAJ; Abdallah M; Tirona MT
    J Investig Med High Impact Case Rep; 2021; 9():23247096211022186. PubMed ID: 34096366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Surgical Management of Inflammatory Breast Cancer.
    Adesoye T; Lucci A
    Ann Surg Oncol; 2021 Oct; 28(10):5461-5467. PubMed ID: 34346020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
    Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
    Lacerda L; Reddy JP; Liu D; Larson R; Li L; Masuda H; Brewer T; Debeb BG; Xu W; Hortobágyi GN; Buchholz TA; Ueno NT; Woodward WA
    Stem Cells Transl Med; 2014 Jul; 3(7):849-56. PubMed ID: 24833589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer.
    Rogé M; Kirova Y; Loap P; Amar S; Servagi S; Nebbache R; Rivin Del Campo E; Clatot F; Thureau S; Thariat J
    Pract Radiat Oncol; 2023; 13(6):e491-e498. PubMed ID: 37295726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.
    Kai M; Kogawa T; Liu DD; Fouad TM; Kai K; Niikura N; Hsu L; Willey JS; Theriault RL; Valero V; Ueno NT
    Clin Breast Cancer; 2015 Feb; 15(1):37-42. PubMed ID: 25258308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
    Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
    Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
    Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis.
    Lai HY; Loh EW; Su CM; Chiang MH; Tam KW
    J Surg Res; 2024 Jan; 293():458-467. PubMed ID: 37820394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
    Rosso KJ; Tadros AB; Weiss A; Warneke CL; DeSnyder S; Kuerer H; Ueno NT; Stecklein SR; Woodward WA; Lucci A
    Ann Surg Oncol; 2017 Oct; 24(10):2981-2988. PubMed ID: 28766220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.
    Raghav K; French JT; Ueno NT; Lei X; Krishnamurthy S; Reuben JM; Valero V; Ibrahim NK
    PLoS One; 2016; 11(1):e0145534. PubMed ID: 26752563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
    Warren LE; Guo H; Regan MM; Nakhlis F; Yeh ED; Jacene HA; Hirshfield-Bartek J; Overmoyer BA; Bellon JR
    Ann Surg Oncol; 2015 Aug; 22(8):2483-91. PubMed ID: 25791789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: a case report and literature review.
    Ben Musa R; Usha L; Hibbeln J; Mutlu EA
    World J Gastroenterol; 2014 May; 20(19):5912-7. PubMed ID: 24914353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy.
    Adesoye T; Everidge S; Chen J; Sun SX; Teshome M; Valero V; Woodward WA; Lucci A
    Ann Surg Oncol; 2023 Oct; 30(10):6232-6240. PubMed ID: 37479842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.